CN112933118A - 用于治疗眼睛的组合物和方法 - Google Patents

用于治疗眼睛的组合物和方法 Download PDF

Info

Publication number
CN112933118A
CN112933118A CN202011302835.4A CN202011302835A CN112933118A CN 112933118 A CN112933118 A CN 112933118A CN 202011302835 A CN202011302835 A CN 202011302835A CN 112933118 A CN112933118 A CN 112933118A
Authority
CN
China
Prior art keywords
pichia
optionally
composition
extract
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011302835.4A
Other languages
English (en)
Chinese (zh)
Inventor
李丁文华
K·马哈迈德
R·伯尔萨
拜明岐
K·T·霍瓦
M·兰达瓦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Surgical Vision Inc
Original Assignee
Johnson and Johnson Consumer Companies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/099,185 external-priority patent/US11969451B2/en
Application filed by Johnson and Johnson Consumer Companies LLC filed Critical Johnson and Johnson Consumer Companies LLC
Publication of CN112933118A publication Critical patent/CN112933118A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
CN202011302835.4A 2019-11-19 2020-11-19 用于治疗眼睛的组合物和方法 Pending CN112933118A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962937473P 2019-11-19 2019-11-19
US201962937458P 2019-11-19 2019-11-19
US62/937458 2019-11-19
US62/937473 2019-11-19
US17/099,185 US11969451B2 (en) 2019-11-19 2020-11-16 Compositions and methods for treating the eye
US17/099185 2020-11-16

Publications (1)

Publication Number Publication Date
CN112933118A true CN112933118A (zh) 2021-06-11

Family

ID=75964158

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011302835.4A Pending CN112933118A (zh) 2019-11-19 2020-11-19 用于治疗眼睛的组合物和方法

Country Status (6)

Country Link
JP (1) JP2021080253A (ko)
KR (1) KR20210061297A (ko)
CN (1) CN112933118A (ko)
AU (2) AU2020273321A1 (ko)
BR (1) BR102020023560A8 (ko)
CA (1) CA3100032A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117268877A (zh) * 2023-11-21 2023-12-22 军科正源(北京)药物研究有限责任公司 检测人泪液中的神经生长因子的方法及其泪液的处理方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1883469A (zh) * 2006-05-26 2006-12-27 朱啟婉 一种含有维生素a和维生素e的眼用微乳及其制备方法
CN102994500A (zh) * 2008-10-22 2013-03-27 夸克医药公司 治疗眼部疾病的方法
CN106692029A (zh) * 2015-11-06 2017-05-24 强生消费者公司 局部用凝胶霜组合物
CN106890114A (zh) * 2015-12-17 2017-06-27 强生消费者公司 包含异常毕赤酵母和菊苣根提取物的局部用组合物
CN108210378A (zh) * 2016-12-12 2018-06-29 强生消费者公司 含有甘油和酵母提取物的局部用组合物
CN108697635A (zh) * 2016-02-08 2018-10-23 索夫特意大利公司 用于治疗与角膜-结膜表面改变有关的眼病的眼科组合物

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1883469A (zh) * 2006-05-26 2006-12-27 朱啟婉 一种含有维生素a和维生素e的眼用微乳及其制备方法
CN102994500A (zh) * 2008-10-22 2013-03-27 夸克医药公司 治疗眼部疾病的方法
CN104857526A (zh) * 2008-10-22 2015-08-26 夸克制药公司 治疗眼部疾病的方法
CN106692029A (zh) * 2015-11-06 2017-05-24 强生消费者公司 局部用凝胶霜组合物
CN106890114A (zh) * 2015-12-17 2017-06-27 强生消费者公司 包含异常毕赤酵母和菊苣根提取物的局部用组合物
CN108697635A (zh) * 2016-02-08 2018-10-23 索夫特意大利公司 用于治疗与角膜-结膜表面改变有关的眼病的眼科组合物
CN108210378A (zh) * 2016-12-12 2018-06-29 强生消费者公司 含有甘油和酵母提取物的局部用组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
顾其胜: "《眼手术并发症原因与处理》", 第二军医大学出版社, pages: 306 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117268877A (zh) * 2023-11-21 2023-12-22 军科正源(北京)药物研究有限责任公司 检测人泪液中的神经生长因子的方法及其泪液的处理方法
CN117268877B (zh) * 2023-11-21 2024-02-20 军科正源(北京)药物研究有限责任公司 检测人泪液中的神经生长因子的方法及其泪液的处理方法

Also Published As

Publication number Publication date
AU2020273321A1 (en) 2021-06-03
KR20210061297A (ko) 2021-05-27
AU2022263530A1 (en) 2022-12-08
BR102020023560A2 (pt) 2021-10-13
BR102020023560A8 (pt) 2023-02-07
CA3100032A1 (en) 2021-05-19
JP2021080253A (ja) 2021-05-27

Similar Documents

Publication Publication Date Title
US11357805B2 (en) Compositions and methods for treating the eye
AU2022246418B2 (en) Compositions and methods for treating the eye
CN115671090A (zh) 用于治疗眼睛的组合物和方法
US11878042B2 (en) Compositions and methods for treating the eye
US11878041B2 (en) Compositions and methods for treating the eye
CN112823789B (zh) 用于治疗眼睛的组合物和方法
US10966948B2 (en) Compositions and methods for treating the eye
AU2022263530A1 (en) Compositions and methods for treating the eye
EP3824877A1 (en) Compositions and methods for treating the eye
US11969451B2 (en) Compositions and methods for treating the eye
RU2795913C2 (ru) Композиции и способы лечения глаз
RU2793736C2 (ru) Композиции и способы лечения глаз
RU2802365C2 (ru) Композиции и способы лечения глаз
RU2802625C2 (ru) Композиции и способы лечения глаз

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40056094

Country of ref document: HK

TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20220623

Address after: California, USA

Applicant after: Johnson & Johnson surgical vision Co.

Address before: new jersey

Applicant before: JOHNSON & JOHNSON CONSUMER COMPANIES, Inc.

SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210611